BACKGROUND: Although in patients with COPD, the approach to daytime hypoxemia using long-term oxygen therapy (LTOT) is established, the best approach to transient nocturnal desaturation varies among clinicians. An understanding of the prevalence of nocturnal desaturation in COPD, in the absence of other respiratory co-morbidities, is an important step towards its standardized management. METHODS: We conducted a 5 site cross-sectional study of stable patients with COPD and mild-to-moderate daytime hypoxemia (PaO(2) 56-69 mmHg). Nocturnal saturation was monitored using home oximetry on 2 occasions over a 2-week period. Patients were classified in 3 categories: (A) no significant nocturnal desaturation; (B) significant nocturnal desaturation without evidence of sleep apnea; (C) significant nocturnal desaturation with evidence of sleep apnea. RESULTS: In 128 patients (mean FEV(1): 37% predicted), we noted an excellent test-retest reliability between the 2 oximetries. Forty-nine patients (38%) were classified as nocturnal desaturators without evidence of sleep apnea, and 20 patients (16%) were classified as desaturators with evidence of sleep apnea. Nocturnal desaturation without sleep apnea could not be predicted by any patient characteristic or physiological measure. CONCLUSIONS: A significant proportion (38%) of patients with moderate-to-severe COPD who do not qualify for home oxygen therapy based on their daytime PaO(2) have nocturnal oxygen desaturation without evidence of sleep apnea. Home oximetry is an effective practical method for screening this population.
BACKGROUND: Although in patients with COPD, the approach to daytime hypoxemia using long-term oxygen therapy (LTOT) is established, the best approach to transient nocturnal desaturation varies among clinicians. An understanding of the prevalence of nocturnal desaturation in COPD, in the absence of other respiratory co-morbidities, is an important step towards its standardized management. METHODS: We conducted a 5 site cross-sectional study of stable patients with COPD and mild-to-moderate daytime hypoxemia (PaO(2) 56-69 mmHg). Nocturnal saturation was monitored using home oximetry on 2 occasions over a 2-week period. Patients were classified in 3 categories: (A) no significant nocturnal desaturation; (B) significant nocturnal desaturation without evidence of sleep apnea; (C) significant nocturnal desaturation with evidence of sleep apnea. RESULTS: In 128 patients (mean FEV(1): 37% predicted), we noted an excellent test-retest reliability between the 2 oximetries. Forty-nine patients (38%) were classified as nocturnal desaturators without evidence of sleep apnea, and 20 patients (16%) were classified as desaturators with evidence of sleep apnea. Nocturnal desaturation without sleep apnea could not be predicted by any patient characteristic or physiological measure. CONCLUSIONS: A significant proportion (38%) of patients with moderate-to-severe COPD who do not qualify for home oxygen therapy based on their daytime PaO(2) have nocturnal oxygen desaturation without evidence of sleep apnea. Home oximetry is an effective practical method for screening this population.
Authors: Jingjing Liang; Brian E Cade; Karen Y He; Heming Wang; Jiwon Lee; Tamar Sofer; Stephanie Williams; Ruitong Li; Han Chen; Daniel J Gottlieb; Daniel S Evans; Xiuqing Guo; Sina A Gharib; Lauren Hale; David R Hillman; Pamela L Lutsey; Sutapa Mukherjee; Heather M Ochs-Balcom; Lyle J Palmer; Jessica Rhodes; Shaun Purcell; Sanjay R Patel; Richa Saxena; Katie L Stone; Weihong Tang; Gregory J Tranah; Eric Boerwinkle; Xihong Lin; Yongmei Liu; Bruce M Psaty; Ramachandran S Vasan; Michael H Cho; Ani Manichaikul; Edwin K Silverman; R Graham Barr; Stephen S Rich; Jerome I Rotter; James G Wilson; Susan Redline; Xiaofeng Zhu Journal: Am J Hum Genet Date: 2019-10-24 Impact factor: 11.025
Authors: Nicolle J Domnik; Devin B Phillips; Matthew D James; Grace A Ayoo; Sarah M Taylor; Robin E Scheeren; Amanda T Di Luch; Kathryn M Milne; Sandra G Vincent; Amany F Elbehairy; Sophie J Crinion; Helen S Driver; J Alberto Neder; Denis E O'Donnell Journal: Eur J Appl Physiol Date: 2022-01-16 Impact factor: 3.346
Authors: Atul Malhotra; Alan R Schwartz; Hartmut Schneider; Robert L Owens; Pamela DeYoung; MeiLan K Han; Jadwiga A Wedzicha; Nadia N Hansel; Michelle R Zeidler; Kevin C Wilson; M Safwan Badr Journal: Am J Respir Crit Care Med Date: 2018-02-01 Impact factor: 21.405
Authors: Yves Lacasse; Sarah Bernard; Frédéric Sériès; Van Hung Nguyen; Jean Bourbeau; Shawn Aaron; François Maltais Journal: BMC Pulm Med Date: 2017-01-09 Impact factor: 3.317
Authors: José Laerte Rodrigues Silva; Marcus Barreto Conde; Krislainy de Sousa Corrêa; Helena Rabahi; Arthur Alves Rocha; Marcelo Fouad Rabahi Journal: J Bras Pneumol Date: 2017 May-Jun Impact factor: 2.624
Authors: Sverre Lehmann; Thomas Ringbæk; Anders Løkke; Ludger Grote; Jan Hedner; Eva Lindberg Journal: Int J Chron Obstruct Pulmon Dis Date: 2019-01-09